🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT03215368
Active, not recruiting Observational

The Ma'Anshan Birth Cohort (MABC)

NCT03215368 · tracked via the Priya Life Science China tracker
Sponsor
Anhui Medical University
Phase
Observational
Started
2013-05-16
Last updated
2024-04-12

Condition(s) studied

Environmental ExposurePregnancy OutcomeBirth DefectsChild DevelopmentMaternal and Child HealthHealth Problems in Pregnancy

Study summary

The Ma'anshan Birth Cohort (MABC) is a population-based prospective pregnancy and birth cohort study that aims to explore the early environmental and genetic determinants of maternal and child health, with a focus on health outcomes including maternal health, children's cognitive and behavioral development, growth and physical development, video-screen behaviors, and asthma and allergic diseases.

MABC was officially launched in May 2013 at the Ma'anshan Maternal and Child Health Hospital in Anhui Province, and a total of 3,474 families were recruited as of September 2014 to continuously track the health status of mother-child pairs during pregnancy, delivery, and childhood, including basic family demographics, maternal pregnancy and birth history and past history, history of exposure to hazardous factors during pregnancy, children's diets and lifestyles, and children's physical and cognitive-behavioral development, MABC quantifies the attributional relationship between environmental chemicals, diet and nutrition, drug safety, psychological stress, lifestyle, biorhythm, endocrine metabolism and adverse birth outcomes, birth defects, neurodevelopmental disorders, developmental disabilities, etc., and identifies environmental, behavioral and genetic causative factors for birth defects and common developmental disorders, and identifies early warning signs and symptoms for early detection of birth defects. genetic causative factors, identify clinical biomarkers with early predictive effects, integrate and form a precise risk evaluation and early warning model, carry out regional comprehensive prevention and treatment applications, and promote the improvement of the quality of the birth population. Currently, MABC is conducting its 20th school-age follow-up visit.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
44 Years
Healthy volunteers
Accepted
Inclusion Criteria 1. Permanent residents of Ma'anshan city; 2. Obstetric examination and delivery at Ma'anshan Maternal and Child Health Hospital; 3. Mother's age ≥ 18 years old and gestational week ≤ 14 weeks; 4. No serious neuropsychiatric disorders, with sufficient understanding and expression to complete the survey. Exclusion criteria: 1. Intellectual disability or other serious mental disorders; 2. Suffering from serious underlying diseases and may have a significant impact on pregnancy outcome; 3. Those with poor compliance and difficulty in follow-up.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ma'anshan Maternal and Child Health Care Hospital Ma’anshan Anhui

More Anhui Medical University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03215368 on ClinicalTrials.gov ↗ ← All trials in China